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Meta-analysisComplex clinical decisions require the decision maker to evaluate multiple factors that may interact with
each other. Many clinical studies, however, report ‘univariate’ relations between a single factor and
outcome. Such univariate statistics are often insufﬁcient to provide useful support for complex clinical
decisions even when they are pooled using meta-analysis. More useful decision support could be pro-
vided by evidence-based models that take the interaction between factors into account. In this paper,
we propose a method of integrating the univariate results of a meta-analysis with a clinical dataset
and expert knowledge to construct multivariate Bayesian network (BN) models. The technique reduces
the size of the dataset needed to learn the parameters of a model of a given complexity. Supplementing
the data with the meta-analysis results avoids the need to either simplify the model – ignoring some
complexities of the problem – or to gather more data. The method is illustrated by a clinical case study
into the prediction of the viability of severely injured lower extremities. The case study illustrates the
advantages of integrating combined evidence into BN development: the BN developed using our method
outperformed four different data-driven structure learning methods, and a well-known scoring model
(MESS) in this domain.
 2014 Elsevier Inc. All rights reserved.1. Introduction
It is a challenge to build effective decision-support models for
complex clinical problems; such problems involve multiple inter-
acting factors [1,2] and to account for both the factors and their
interaction a ‘multivariate’ model is needed [3]; these can have
many forms: our focus is on Bayesian networks. In general, a
multivariate model can be built in a number of ways: (1) purely
from data using statistical and machine learning techniques [4],
(2) from a combination of clinical knowledge and data [5–7] or
(3) from published literature using multivariate meta-analysis
techniques [8]. Each of these techniques has been shown to be suc-
cessful in certain conditions but in this paper, we focus on clinical
problems where none of these techniques is sufﬁcient, on its own,
to build a useful decision support model. That is, our focus is on
problems that are complex, important but also rare: their raritymakes it hard to collect very large datasets (so called ‘big data’);
their complexity demands a sophisticated multivariate model but
their importance ensures that a large number of relevant research
studies is available.
In these domains, the ﬁrst method of building models – purely
from data – results in simplemodels that cannot deal with the com-
plexity of the problem [1] because there is not enough data to sup-
port a complex model. The third approach fails because clinical
studies rarely publish information detailed enough for multivariate
meta-analysis [9]. Instead, manymedical studies report ‘univariate’
relations between a single factor and an outcome. Randomised con-
trolled trials, for example, analyse the effect of a single treatment by
using randomisation to decrease the confounding effect of other
variables [10]. Similarly, many observational studies report the
relation between individual risk factors and outcomes even when
their dataset contains information about multiple factors. The sec-
ond approach – combining knowledge and data – could work but it
ignores the large body of published evidence; our challenge is
therefore to exploit the results of a meta-analysis of studies report-
ing univariate relations to supplement a dataset that is otherwise
inadequate to support a complex multivariate model.
Fig. 1. Bayesian meta-analysis model for combining probabilities.
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the effects of interactions between variables are not taken into
account. For example, evidence about individual effects of a
treatment and a comorbidity factor can be analysed in separate
meta-analyses. However, if the treatment and comorbidity factor
interact with each other, their joint effect may be completely dif-
ferent from their individual effects. As a result, decision support
provided by the meta-analysis of individual effects may be invalid
for a patient who is exposed to both the treatment and the comor-
bidity factor (see [2,10,11] for a more detailed discussion of gener-
alising clinical evidence).
To improve this situation, we propose a method of combining
the results of meta-analyses, clinical knowledge and data to pro-
vide decision support for complex decision problems where the
data is scarce. Our method combines ‘univariate’ meta-analysis fol-
lowing a systematic review, with a small ‘multivariate’ dataset and
expert knowledge. Bayesian networks (BN) offer a powerful frame-
work to combine evidence from different sources [1,5,12,13]. Our
methodology integrates the evidence from a meta-analysis into
BN development by using it ﬁrst to identify the BN structure and
then to help determine the BN parameters; this second step uses
auxiliary parameter learning models similar in some ways to tech-
niques that can be used for meta-analysis. We illustrate the appli-
cation and results of this method with a clinical case study into the
prediction of the outcomes of severely injured lower extremities.
In the remainder of this paper, Section 2 recaps of a Bayesian
meta-analysis technique to combine probabilities. Section 3
describes our methodology for developing a BN based on the
results of a meta-analysis. Sections 4–6 present the case-study,
results and conclusions respectively.2. Meta-analysis of probabilities
The method we propose in Section 3 assumes a possibly small
multivariate patient dataset is available together with univariate
results of a meta-analysis of probabilities. In this section, we give
a recap of the meta-analysis of probabilities by brieﬂy presenting
an existing Bayesian technique [14,15]. The results obtained from
this meta-analysis technique can be used in the method of Sec-
tion 3, though other techniques could also be used. The recap also
serves to introduce hierarchical Bayesian models, which are also
used in Section 3.
Meta-analysis is an important form of clinical evidence as it
combines and summarises the relevant published evidence that
is identiﬁed by a systematic literature review. Meta-analysis can
be used to combine different types of statistics including odds
ratios, risk ratios and probabilities [14]. We focus on the meta-
analysis of probabilities as the parameters of a BN are composed
of probabilities. Fig. 1 shows a random-effects Bayesian meta-
analysis model that takes the variation between studies into
account, and does not assume normality for the distribution of
the individual studies.
The binomial distribution is the probability distribution of the
number of positive outcomes in n independent experiments where
the probability of a positive outcome is p for every experiment. In
the meta-analysis model, the result of each individual study i is
modelled with the binomial distribution shown below, where ri
is the number of positive outcomes observed in the study i, pi is
the true study probability of the study i, and ni is the sample size
of the study i.
ri  Binomialðpi;niÞ
The normal distribution is a convenient way of modelling the
pooled estimate and the variation between studies. We use an
inverse logit transformation to model the true study probabilitypi with the normal distribution. The mean l of this distribution
represents the transformed pooled estimate, and the variance s2
represents the variation between studies.
logitðpiÞ ¼ hi
hi  Normalðl; s2Þ
The predictive probability distribution can also be calculated by
using an inverse logit transformation of this normal distribution.
The predictive distribution is a recommended way of presenting
the results of a meta-analysis as it represents the uncertainty from
both the pooled estimate and the variation between studies (see
[14] and chapter 8 of [16] for more detailed information on
predictive distributions in meta-analysis).
hnew  Normalðl; s2Þ
logitðpnewÞ ¼ hnew
Finally, priors must be selected for the pooled estimate and
between-study standard deviation. The non-informative priors
shown below can be used if informative priors are not available.
l  Normalð0;1000Þ
s  Uniformð0;2Þ
In order to calculate the posteriors of l, s2 and pnew, we enter the
observed number of positive outcomes ri and sample sizes ni from
each reviewed study. The posteriors can be calculated by using
the dynamic discretisation algorithm [17] in AgenaRisk [18] or the
Markov Chain Monte Carlo (MCMC) sampling technique in
OpenBUGS [19].
3. Building BNs based on meta-analysis
The previous section described a Bayesian meta-analysis tech-
nique for pooling probabilities. In this section, we present a meth-
odology that uses data, expert knowledge and the pooled
probabilities from a meta-analysis to deﬁne the structure (Sec-
tion 3.1) and parameters (Section 3.2) of a BN decision support
model. Our methodology assumes that expert knowledge, a
meta-analysis of univariate relations from a relevant systematic
B. Yet et al. / Journal of Biomedical Informatics 52 (2014) 373–385 375review and some data about multivariate relations are available.
However, the amount of data may be insufﬁcient to learn the
parameters of some relations in the BN.
3.1. Structure
A BN structure can be developed in two stages: selecting vari-
ables, and identifying the relations between those variables.
Domain experts use the results of a meta-analysis to select the
important variables for the BN. The experts review every variable
that is considered to be clinically important in the meta-analysis.
During the review, they deﬁne mechanistic relations between each
of these variables and the outcome. These deﬁnitions enable us to
(1) build a causal BN structure that is consistent with clinical
knowledge and (2) identify the variables that are clinically impor-
tant considering the aims and scope of the model. Variables that
are outside the scope of the model are excluded even when they
have a clinically signiﬁcant effect in the meta-analysis.
The mechanistic relations between the observed factors and
outcome may depend on clinical factors that are not available in
the data or not examined in the meta-analysis. For example, the
data may not distinguish between the measurements and true
state of a variable, or may exclude a part of the important causal
factors in the domain (see [6] and chapters 1 and 2 of [20] for a
more detailed discussion of this issue). In this case, latent variables
are used to model clinical knowledge in the BN.
3.2. Parameters
Meta-analysis of a univariate relation provides a probability
conditioned on a single variable, such as P(Y|X1). Such probability
distribution cannot be directly used for a BN variable that is condi-
tioned on multiple parents such as P(Y|X1, ... ,Xn). In this section, we
present a parameter learning method for combining the results of a
univariate meta-analysis and data to learn the parameters of a BN
variable that has multiple parents. Our method uses auxiliary
Bayesian models to learn the parameters of the BN used for deci-
sion support. These auxiliary models are hierarchical models with
a structure that is conceptually similar to the Bayesian meta-anal-
ysis model described in Section 2. We introduce the proposed
method by a simple example in Section 3.2.1, and examine the
application of this method to more complex BN models in
Section 3.2.2. The conditional probabilities provided by a meta-
analysis may be relevant to variables that are not directly linked
in the BN structure. We examine this issue in Section 3.2.3.
3.2.1. Illustration of the parameter learning method
In this section, we introduce our parameter learning method
with the simple BN shown in Fig. 2.
This BN has 3 variables and each of its variables has 2 states:
X1 ¼ x11; x21
 
X2 ¼ x12; x22
 
Y ¼ fy1; y2gFig. 2. Simple BN used for illustrating the parameter learning method.The conditional probability distribution (CPD) of a discrete var-
iable is encoded in a node probability table (NPT) in a BN. Table 1
shows the NPT of the variable Y. We require 4 parameters for this
NPT: Pðy1jx11; x12Þ; Pðy1jx11; x22Þ; Pðy1jx21; x12Þ and Pðy1jx21; x22Þ.
The parameters of the variable Y can be learnt from data using
the maximum likelihood estimate (MLE) approach. For example,
Pðy1jx11; x12Þ) can be estimated by dividing M½y; x11; x12 to M½x11; x12,
where M½y; x11; x12 represents the count of data instances where
Y = y1, X1 ¼ x11 and X2 ¼ x12, and M½x11; x12 represents the count of
data instances where X1 ¼ x11 and X2 ¼ x12.
P y1jx11; x12
  ¼ M½y
1; x11; x
1
2
M½x11; x12
Suppose we have a dataset, with a sample size of M = 250, to
learn the parameters of the BN in Fig. 2. Fig. 3 shows a part of
the relevant counts from this imaginary dataset. There are only 3
data instances where Y = y1, X1 ¼ x11 and X2 ¼ x12 as shown by
M½y1; x11; x12 ¼ 3 in this ﬁgure.
Our aim is to estimate the parameters of the BN. Although the
overall sample size of the data is not small, there is not an adequate
amount of data for learning some of the parameters. For example,
there are only a few data instances to learn the probability of
Pðy1jx11; x12Þ since M½y1; x11; x12 ¼ 3 and M½x11; x12 ¼ 10.
As well as the data, suppose we have the results of a meta-
analysis that analyses the relation between Y and X1. This meta-
analysis pools the conditional probabilities of Pðy1jx11Þ reported in
different studies. The result of the meta-analysis is reported by
the mean, lpnewðy1jx11Þ, and variance, r2pnewðy1jx11Þ, of the predictive
distribution of the pooled conditional probability (see Table 2). A
way of calculating these statistics is described in Section 2.
The results of the meta-analysis cannot be directly used for the
BN parameters since the variable Y is conditioned on both X1 and
X2 in the BN model whereas it is conditioned only on X1 in the
meta-analysis. In other words, there is no parameter to use
Pðy1jx11Þ directly in the NPT of the variable Y (see Table 1).
In the remainder of this section, we present a novel technique
that combines the data shown in Fig. 3 and themeta-analysis results
shown in Table 2 to learn the parameters Pðy1jx11; x12Þ and Pðy1jx11; x22Þ
for the NPT of the variable Y. The generalisation of this method for a
larger number of parents and states is described in Section 3.2.2.
Fig. 4 shows a BN representation of the implemented technique.
The BN representation is divided into ﬁve components that are
described in the remainder of this section:
1. Data: This part uses the binomial distribution to model the
relation between the conditional probability distributions
(CPD) that we aim to estimate and the observed counts in the
data. For example, the number of data instances where
X1 ¼ x11, X2 ¼ x12 and Y = y1, shown by M½y1; x11; x12, has a bino-
mial distribution where the probability parameter is
Pðy1jx11; x12Þ and the number of trials parameter is M½x11; x12. The
binomial distributions used in this part are shown below:Table 1
NPT of
Y = y
Y = yM y1; x11; x
1
2
   Binomial M x11; x12
 
; P y1jx11; x12
  M y1; x11; x
2
2
   Binomial M x11; x22
 
; P y1jx11; x22
  the variable Y.
X1 ¼ x11 X1 ¼ x11 X1 ¼ x21 X1 ¼ x21
X2 ¼ x12 X2 ¼ x22 X2 ¼ x12 X2 ¼ x22
1 Pðy1jx11; x12Þ Pðy1jx11; x22Þ Pðy1jx21; x12Þ Pðy1jx21; x22Þ
2 1 Pðy1jx11; x12Þ 1 Pðy1jx11; x22Þ 1 Pðy1jx21; x12Þ 1 Pðy1jx21; x12Þ
Fig. 3. Relevant counts from the data.
Table 2
Predictive distribution parameters from the meta-
analysis.
Meta-analysis of Pðy1jx11Þ
Predictive distribution parameters
lpnewðy1jx11Þ 0.2
r2pnewðy1jx11Þ 0.005
376 B. Yet et al. / Journal of Biomedical Informatics 52 (2014) 373–385M½x12  Binomial M; Pðx12Þ
 M½x22  Binomial M; Pðx22Þ
 Fig. 4. BN representation of the auxi2. Probability distributions for NPT: This part contains the CPDs that
we aim to estimate for the NPT of Y. We assign uniform priors
for these distributions, informative expert priors can also be
used when available:liary paPðy1jx11; x12Þ  Uniformð0;1ÞPðy1jx11; x22Þ  Uniformð0; 1Þ
3. Marginalisation of NPT distributions: Since the variable Y is con-
ditioned only on 1 variable in the meta-analysis and 2 variables
in the BN, we model the probability distribution from the meta-
analysis, Pðy1jx11Þ, as the marginalisation of the probability dis-
tribution from the BN parameters Pðy1jx11; x12Þ and Pðy1jx11; x22Þ:rameter learning model.
Fig. 5.
method
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X
X2
ðPðy1jx11;X2Þ  PðX2ÞÞ
¼ Pðy1jx11; x12ÞPðx12Þ þ Pðy1jx11; x22ÞPðx22Þ
4. Probabilities required for marginalisation: In order to calculate
the marginalisation in part 3, we need the probability distribu-
tions of Pðx12Þ and Pðx22Þ. We assign uniform priors for these
variables. We also assign a constraint to ensure that the sum
of Pðx12Þ and Pðx22Þ is equal to 1.Pðx12Þ  Uniformð0;1ÞPðx22Þ  Uniformð0;1ÞX
X2
PðX2Þ ¼ Pðx12Þ þ Pðx22Þ ¼ 15. Values from meta-analysis: The pooled estimate lpnewðy1jx11Þ
from the meta-analysis is modelled with the normal distribu-
tion truncated to a unit interval as it represents a probability
value, denoted by TNormal[0, 1] (l, r2). We use Pðy1jx11Þ from
the marginalisation in part 3 and r2pnewðy1jx11Þ from the predic-
tive distribution as the mean and variance of this normal distri-
bution respectively. The values from the meta-analysis are
modelled as:lpnewðy1jx11Þ  TNormal½0;1ðPðy1jx11Þ;r2pnewðy1jx11ÞÞ
After the observations from the data and meta-analysis are entered
to the BN (see Fig. 4), the posteriors for Pðy1jx11; x12Þ and Pðy1jx11; x22Þ
can be calculated. Note that, the NPT of Y requires point estimates
for Pðy1jx11; x12Þ and Pðy1jx11; x22Þ whereas our model calculates the
entire probability distribution of these parameters. Therefore, we
take the mean of these distributions for the point estimates
required for the NPT (see Section 17.4 of [21] for a discussion of
the use of posterior distributions for BN parameters).
In the following section, we describe the generalisation of this
technique for estimating the parameters of variables with more
parents or states.
3.2.2. Application of the parameter learning method for more complex
BNs
Let Y be a BN variable that has n parents, and X = {X1, X2, . . ., Xn}
be the set of parents of Y (see Fig. 5). Both Y and its parents have
multiple states:
Y ¼ fy1; . . . ; ykg
Xi ¼ fx1i ; . . . ; xki g
Our dataset contains a total of M data instances about X and Y
(see Table 3). We also have pooled conditional probability and
variance estimates of the predictive distribution of P(Y|Xi) from a
meta-analysis (see Table 4). A way of calculating these predictive
distributions is described in Section 2.BN with n parents used for illustrating the generalised parameter learning
.Fig. 6 shows an abstract graphical illustration of the generalised
auxiliary parameter learning model. This model is a generalisation
of the model shown in Fig. 4. This illustration is not a BN; it is a
schema for building an auxiliary parameter learning model for
any number of states and parent variables. The size of the auxiliary
parameter learning model grows rapidly with increasing number
of parents and states.
In Fig. 6, the variables shown by ellipses are unknown variables
that will be estimated by the model. The variables shown by
rounded rectangles are observed with the values from the meta-
analysis, and the variables shown by rectangles are observed from
the dataset. The constraints that sum probabilities to 1 are not
included in this ﬁgure to simplify the illustration. By running this
auxiliary model, we estimate probability distributions for the
parameters P(Y|X) required by the NPT of Y. Since the BN requires
only a point estimate of the parameter, not the entire distribution;
we use the mean of this distribution as the BN parameter.
According to our model, the data related to Y, i.e.M[Y, X], is gen-
erated by the binomial distribution with the probability of success
P(Y|X) and the number of trials M[X].
M½Y ;X  BinomialðM½X; PðYjXÞÞ
M[Y, X] represents the count of data instances for speciﬁc values of
X1, . . ., Xn and Y. For example, M½y2; x11; x32; . . . ; x4n represents the
number of data instances where Y ¼ y2;X1 ¼ x11;X2 ¼ x32; . . . ;
Xn ¼ x4n. Similarly M[X] represent the number of data instances
where X1, . . ., Xn have certain values.
Our aim is to estimate the CPD of P(Y|X). We assign a uniform
prior for this distribution; informative expert priors can also be
used when available.
PðYjXÞ  Uniformð0; 1Þ
The meta-analysis results are conditioned on a fewer variables
than the CPD in the BN. Therefore, the expected values of the
meta-analysis results are modelled as a marginalisation of the
CPD. The meta-analysis provided the pooled conditional probabil-
ity estimates about P(Y|Xi) that are modelled as the marginalisation
of P(Y|X)
PðYjXiÞ ¼
X
XnfXig
PðY jXÞPðX n fXigÞ
PðX n fXigÞ is also estimated by the binomial distribution below
where M denotes the total number of data instances, and
M½X n fXig denotes the counts of data instances with X n fXig.
PðX n fXigÞ has a uniform prior.
M½X n fXig  BinomialðM; PðX n fXigÞÞ
PðX n fXigÞ  Uniformð0;1Þ
The pooled estimates from the meta-analysis lPnewðY jXiÞ are mod-
elled with a normal distribution truncated to a unit interval [0–1]
as it represents a probability. The mean of this distribution is the
marginalisation of the CPD, i.e. P(Y|Xi), and the variance r2PðYjXiÞ
represents the degree of uncertainty we assign to the meta-
analysis results. We enter the mean and variance of the predictiveTable 3
Sample learning dataset.
Y X1 . . . Xn
1 y4 x31 . . . x
2
2
2 y2 x21 . . . x
1
2
: : : :
: : : :
M y1 x11 . . . x
4
2
Table 4
Sample meta-analysis results.
lPnew r2Pnew
P(Y|X1). 0.13 0.007
P(Y|X2). 0.21 0.025
: : :
: : :
P(Y|Xn). 0.19 0.001
Fig. 7. BN with an intermediate variable.
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r2PnewðYjXiÞ. We use the truncated normal distribution as it is conve-
nient to deﬁne the expected value and variance parameters for it
but lPnewðYjXiÞ may not be normally distributed as it represents a
probability value between 0 and 1.
lPnewðY jXiÞ  TNormal½0;1ðPðYjXiÞ;r2PnewðYjXiÞÞ
Finally, we introduce constraints to ensure that the sum of
every probability distribution is equal to 1.
X
Y
PðYjXÞ ¼ 1
X
XnfXig
PðX n fXigÞ ¼ 1
X
Y
PðYjXiÞ ¼ 13.2.3. Meta-analysis results for non-neighbour variables
The method described in Sections 3.2.1 and 3.2.2 assumes that
the variables analysed in the meta-analysis are neighbours in the
BN. In this section we look at how this assumption can be relaxed
tohandle themore general casewhere the BNcontains other – inter-
mediate – variables between the variables analysed in the meta-
analysis. This situation is illustrated in Fig. 7; the meta-analysis
combines the published probabilities for P(Y|X) but the BN contains
another variable I betweenX and Y so that the values in P(Y|X) are no
longer parameters of the BN.We examine howwe can use informa-
tion from ameta-analysis about non-neighbouring variables to esti-
mate the parameters of a variable in the BN. In particular, we use
P(Y|X), calculated from a meta-analysis, to estimate P(I|X), giving
the parameters of the X? I relation, when we know or have data
for P(Y|I) describing the other intermediate relation I? Y.
Since every variable in a BN is conditioned on its parents, P(Y|X)
provided from the meta-analysis is equal to:Fig. 6. Graphical illustration of the generalisPðY jXÞ ¼
X
I
PðYjIÞPðIjXÞ
Based on this, we can estimate every parameter of P(I|X) as:
PðikjXÞ ¼ PðYjXÞ 
P
m2SPðYjimÞPðimjXÞ
PðYjikÞ
In this equation, S is the set of states of the variable I except the
state ik:
S ¼ ValðIÞ n fikg
Consequently, the parameters of P(I|X) can be estimated given
that meta-analysis provides us with P(Y|X), and we know or have
data to learn P(Y|I). In order to get a point estimate for parameters
of P(I|X), the number of the states of I must not exceed the number
of the states of Y. Otherwise, we can get an interval for the values in
P(I|X) but cannot estimate the exact values.
For example, let X, I and Y in Fig. 7 have two states each with the
values {x1, x2}, {i1, i2}, {y1, y2} respectively. Suppose a meta-analysis
provides us with P(y1|x1) = 0.8, and we learn the probabilities
P(y1|i1) = 0.9, P(y1|i2) = 0.3 from the data. Since I has two states:
P(i2|x1) = 1  P(i1|x1). From these values, we can calculate P(i1|x1)
as:
Pði1jx1Þ ¼ Pðy
1jx1Þ  Pðy1ji2ÞPði2jx1Þ
Pðy1ji1Þ
¼ Pðy
1jx1Þ  Pðy1ji2Þð1 Pði1jx1ÞÞ
Pðy1ji1Þ
¼ 0:833
When I has more states than Y, we cannot get the exact values of the
BN parameters but we can ﬁnd an interval of possible values. Let I
has the states {i1, i2, i3} instead of {i1, i2}. Since I has three states,
P(i3|x1) = 1  P(i1|x1)  P(i2|x1). Let P(y1|i3) = 0.5, and the other
values be the same as in the example above. The parameters of
P(i1|x1) can be calculated by solving the equation below, for each
independent value of Y:
Pði1jx1Þ ¼ PðYjx
1Þ  ðPðY ji2ÞPði2jx1Þ þ PðY ji3ÞPði3jx1ÞÞ
PðYji1Þed auxiliary parameter learning model.
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diate variable I has more states than Y, resulting in more unknowns
than equations. Instead, P(I|x1) can get any value as long as it satis-
ﬁes the following conditions:
Pði2jx1Þ ¼ 1:5þ 2Pði1jx1Þ
Pði3jx1Þ ¼ 2:5 3Pði1jx1Þ
0 6 PðIjx1Þ 6 1
We could use expert knowledge, by eliciting additional con-
straints, to narrow down the set of acceptable values for the
parameters of I. In our example, P(i1|x1) can get any value between
0.75 and 0.83 to satisfy the conditions above. However, some of
these values may not make sense to the domain experts, and we
can eliminate these values by adding additional constraints. For
example, the experts could say that P(i1|x1) should only get values
above 0.8 and we could reﬂect it by adding the P(i1|x1) > 0.8 con-
straint to the conditions above.
The technique described above can also be applied when more
intermediate variables are present. Fig. 8 shows a BN that has n
intermediate variables between Y and X. A similar case, where 2
intermediate variables are present, is encountered in the case
study described in the following section (see Section 4.4.1). An
exact estimate can be found given that we know or have data for
P(Y|X), P(Y|Ik) for k = 2, . . ., n, and that Y does not have fewer states
than I1.
Pðik1jXÞ ¼
PðY jXÞ Pm2SPðY jInÞPðInjIn1Þ . . . PðI2jim1 ÞPðim1 jXÞ
PðYjik1Þ
where S ¼ ValðI1Þ n fik1g.
4. Case-study
Using the method described in Section 3, we developed a BN to
predict viability of a Lower Extremity with Vascular Trauma
(LEVT). This section presents the development of the LEVT BN,
and Section 5 presents its results.
4.1. Background
Injuries to the blood vessels of the lower extremity are poten-
tially devastating and can result in death, severe disability or limb
loss. Delays or errors in treatment decisions may lead to irrevers-
ible consequences and worsen outcome. One of the most difﬁcult
surgical decisions is whether to attempt salvage or perform an
amputation of a severely injured extremity. Accurate risk stratiﬁ-
cation and outcome prediction, for a given injury pattern, has the
potential to improve outcome by reducing delays and errors in
decision-making.
Limb tissues may be permanently damaged as a direct conse-
quence of the energy transfer during injury or die because of a pro-
longed disruption to their blood supply. The extent of tissue
damage, or loss, is directly related to future outcome and is the pri-
mary determinant of the need for amputation. Following a lower
extremity vascular injury, early reperfusion of the affected tissues
is essential to ensure their viability. Reperfusion entails surgical
reconstruction of the damaged blood vessels. Predicting the out-
come of vascular reconstruction and the projected tissue viabilityFig. 8. BN with multiple intermediate variables.would inform treatment decisions and risks. We developed a BN
model for predicting the viability of a traumatic lower extremity
with vascular injury after salvage is attempted. The BN is built in
collaboration with the Trauma Sciences Unit at the Royal London
Hospital and the United States Army Institute of Surgical Research
(USAISR). Two trauma surgeons (the 2nd and 4th authors) were
involved in development of the LEVT BN. A dataset of 521 lower
extremity injuries and 487 patients collected by USAISR, and a
systematic review and meta-analysis of the relevant prognostic
factors were used to develop the LEVT BN.
4.2. Meta-analysis for lower extremity vascular trauma
A number of research studies that describe the factors that
affect outcome following LEVT have been published. Our ﬁrst step
was to conduct a systematic review of these studies and perform a
meta-analysis of the factors. The systematic review included 45
articles containing information regarding 3164 lower extremity
repairs. The study protocol is published in the PROSPERO register
of systematic reviews [22].
We used the model described in Section 2 to pool the relevant
conditional probabilities and calculate the predictive distributions.
The meta-analysis models were calculated using AgenaRisk [18].
Table 5 shows the means and variances of the posterior predictive
distributions. In the following sections, we use these results to
deﬁne the structure and parameters of a BN model.
4.3. Deriving the BN structure
The structure of the BN was deﬁned using the methodology
described in Section 3.1. The systematic review identiﬁed clinical
factors that are potentially associated with the outcome of interest.
A meta-analysis of these factors identiﬁed the strength of this asso-
ciation (see Table 5). A domain expert (2nd author) examined these
variables and described the mechanistic relation between each of
the variables and the outcome. These relations were modelled in
a causal BN structure. Knowledge of mechanistic relations enabled
us to identify variables outside the intended scope of the BN. For
example, nerve injuries were not included in the model even
though they are associated with an increased probability of ampu-
tation. The domain expert identiﬁed that although nerve injuries
may affect function of the related tissues (sensation and move-
ment) they do not affect viability of the tissue. As the intended
scope of our model was to predict limb viability, this variable
was excluded.
For some variables, our dataset held more detailed information
than the results of the meta-analysis. For example, soft-tissue
injury was identiﬁed as one of the most important prognostic vari-
ables by the meta-analysis, the information in our dataset allowed
us to model this variable in more detailed states for the BN. Simi-
larly, detailed information on the degree of ischaemia was present
in the dataset but not in the meta-analysis. Therefore, the BN mod-
els some variables in more detail than the information obtained
from the meta-analysis.
Several latent variables were introduced as the domain expert
identiﬁed the mechanistic relations between the observed clinical
factors and outcomes. These variables were clinically important
but neither the dataset nor the reviewed studies contained them
as they cannot be directly observed [6]. For example, both soft tis-
sue injuries and vessel injuries that require a graft repair have high
probabilities of amputation in the meta-analysis. However, each of
these factors is related to amputation through a different mecha-
nism. Graft repairs can lead to amputation if the graft blocks or
bursts, and thus disrupts the blood ﬂow to the extremity. A vari-
able representing the degree of ‘blood supply’ is required to model
this relation. Although the degree of blood supply can be estimated
Table 5
Mean and variances of the predictive distributions from the meta-analysis for
P(amputation|clinical factor).
Clinical factor Predictive distribution
lPnew r2Pnew
Arterial repair
Graft 0.11 0.009
Primary repair 0.05 0.002
Anatomical site
Femoral 0.04 0.004
Popliteal 0.14 0.005
Tibial 0.10 0.018
Associated injuries
MAIa – present 0.18 0.045
MAIa – absent 0.09 0.006
Soft tissue – present 0.26 0.066
Soft tissue – absent 0.08 0.009
Fracture – present 0.14 0.013
Fracture – absent 0.02 0.001
Nerve – present 0.12 0.022
Nerve – absent 0.06 0.016
Complications
Shock – present 0.13 0.047
Shock – absent 0.06 0.030
Ischaemia time > 6 h 0.24 0.050
Ischaemia time 6 6 h 0.05 0.009
CSb – present 0.28 0.008
CSb – absent 0.06 0.002
a MAI = Arterial Injuries at Multiple Levels.
b CS: Compartment Syndrome.
Table 6
Observed and latent variables in LEVT BN.
Observed variables Latent variables
Arterial Repair Blood Supply
Anatomical Site Ischaemic Damage
Multiple Levels (MAI) Microcirculation
Soft Tissue Injury Soft Tissue Cover
Associated Fracture
Shock
Ischaemia Time
Ischaemia Degree
Compartment Syndrome
Repair Failure
Number of Injured Tibials
Nonviable Extremity
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cult to observe and therefore is not available in the dataset. Soft tis-
sue injuries lead to amputation if insufﬁcient tissue remains to
allow repair. Similarly, a latent variable representing the degree
of ‘soft tissue cover’ is required to model this relation. Table 6
shows a list of the observed and latent variables in the LEVT BN
structure. These variables and the LEVT BN structure are described
in the following section.
The LEVT BN is divided into 5 components, corresponding to the
5 boxes shown in Fig. 9. A summary of the variables and relations
in each of these components are shown below:
 Lower extremity outcome: A viable lower extremity requires an
adequate blood supply and sufﬁcient viable soft tissue to allow
a repair. The ‘Nonviable Extremity’ variable represents extrem-
ities that are amputated as a result of insufﬁcient viable tissue.
‘Nonviable Extremity’ is the main outcome variable that the
LEVT BN aims to predict.
 Ischaemia: Tissue ischaemia results when there is an imbalance
between the supply of oxygen to tissue and the tissues oxygen
requirements to sustain life. This results from a disruption in
the blood supply to the tissue. Initially ischaemiamay be revers-
ible, but if prolonged will result in permanent death of the
affected tissues. Since our model is built for lower extremities
with vascular injuries, most of the extremities within the scope
of ourmodelwill be partly or completely ischaemic until the vas-
cular injury is repaired. The severity of ischaemic damage
depends on the time elapsed since the beginning of ischaemia
(Ischaemia Time) and the degree of obstruction (Ischaemia
Degree). A second important cause of ischaemia is the develop-
ment of a complication called compartment syndrome. Compart-
ment syndrome results when the swelling of injured tissues
compresses the blood vessels, disrupting the blood supply.
 Soft tissue damage: This part of the model predicts the projected
amount of viable soft tissue in the lower extremity. A critical
amount of soft tissue is necessary to repair the lower extremityand protect it from infection. Therefore, the degree of soft tissue
cover is one of the main factors affecting limb viability. Our
model estimates the amount of soft tissue (Soft Tissue Cover)
based on the amount of non-viable tissue due to the direct dam-
age from the injury (Soft Tissue Injury) and ischaemia (Ischae-
mic Damage). Certain injury types (Mechanism of Injury),
such as blast injuries, are likely to cause more severe soft tissue
injuries.
 Success of arterial repair: This part of the model predicts the suc-
cess of a vascular repair operation represented by the ‘Repair
Failure’ variable. ‘Arterial Repair’ variable represents the type
of the repair operation, and have two states: ‘Graft’ and ‘Primary
Repair’. ‘Graft’ represents bypassing of the injured artery by a
vein harvested from the patient. ‘Primary repair’ represents a
simpler repair operation such as stitching of a small laceration
in the artery. ‘Graft’ repairs have higher rate of failure compared
to ‘Primary Repair’ as this operation is more complex and
applied to more severe cases. Injury characteristics often deﬁne
the type of the arterial repair. For example, an arterial injury
cannot be treated by primary repair if a signiﬁcant part of the
artery is missing, thus a graft is necessary.The ‘Multiple Levels’ variable represent whether vascular
injuries are present at multiple levels of the same extremity.
Repairs of such injuries have a higher probability of failure
as they are more likely to block.
‘Anatomical Site’ variable represents the location of the main
arterial injury. Our model includes injuries above the knee
(femoral artery), at the knee (popliteal artery) or below the
knee (tibial arteries). Reconstruction of a femoral artery
often has better outcomes compared to a popliteal or a tibial
artery.
 Blood circulation: ‘Blood Supply’ variable represents the degree
of blood supply to the lower extremity. This variable essentially
depends on the ‘Repair Failure’ variable. If the vascular repair
fails, the extremity will not have adequate blood supply; so
there is a deterministic relation between the negative repair
failure and inadequate blood supply. In other words, a repair
failure leads to inadequate blood supply, and inadequate blood
supply leads to a non-viable extremity in our model. However, a
successful arterial repair may not guarantee adequate blood
supply throughout the lower extremity; side factors including
‘Shock’ and ‘Microcirculation’ can also affect the outcomes.
The ‘Shock’ variable represents an overall deﬁciency of blood
supply throughout the body. The ‘Microcirculation’ variable
represents the severity of injury in the smaller vessels of the
lower extremity.
A single vessel supplies blood to the lower extremity. This
divides into three branches, called tibial arteries, below the knee.
Modelling tibial arteries is important since, in this segment, limb
Fig. 9. Lower extremity vascular trauma Bayesian network.
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to model this difference, we modiﬁed the BN structure for injuries
below the knee by adding a variable about the number of injured
tibial arteries. This modiﬁcation is shown by the variable with
dashed lines in Fig. 10. Our model assumes that a repair failure
leads to a non-viable extremity if all 3 tibial arteries are injured.
However, there is a chance of a successful outcome if only 1 or 2
tibial arteries are injured. Apart from this difference, the BNmodels
for above the knee, at the knee and below the knee injuries are
exactly the same.
4.4. Learning parameters
After building the BN structure, we examined the amount of
data available for learning each parameter in the BN. The data were
insufﬁcient, or not available, to learn the parameters of some rela-
tions. In this section, we describe the techniques used to learn the
parameters when they have (1) insufﬁcient amount of data, (2) no
data at all (latent variables), and (3) adequate amount of data.
4.4.1. Variables with insufﬁcient data
When there is insufﬁcient data to learn a parameter, we com-
bined the results of the meta-analysis and data by using the tech-
nique described in Section 3.2. We used the mean and variance of
the relevant predictive distributions from the meta-analysis (see
Table 5) as observations to the lPnew and r2Pnew variables in the aux-
iliary learning model of this technique (see Fig. 6). For example,
Table 7 shows the amount of available data to learn the NPT of
the ‘repair failure’ variable. The data is not evenly distributed to
learn this NPT. While there is plenty of data to learn some param-
eters, only a few instances is available to learn others. We used the
meta-analysis results for the parameters that have less than 20
instances of data (shown by bold fonts in 7). We observed that
using meta-analysis results did not change the probabilities signif-
icantly when it was applied to the parameters with more than 20
instances of data in our case study. Therefore, we used a purely
data driven approach for those parameters (see Section 4.4.3).
However, it should be noted that different thresholds may be
suitable to other applications in different domains.
The meta-analysis provides us the pooled probabilities of an
unsuccessful outcome conditioned on each individual clinicalfactor (see Table 5). The variable equivalent to an unsuccessful out-
come is ‘nonviable extremity’ in the LEVT BN but the meta-analysis
results can also be used for the NPT of the ‘repair failure’ variable as
(1) our model assumes a deterministic relation between an unsuc-
cessful outcome and repair failure, and thus we know the parame-
ters of the intermediate variables between them and (2) the
parents of ‘repair failure’ can inﬂuence ‘nonviable extremity’
through only one pathway (see Section 3.2.3). For example, the
‘arterial repair’ variable can affect ‘nonviable extremity’ through
the following pathway in our model:
Arterial Repair
ðARÞ
! Repair Failure
ðRFÞ
! Blood Supply
ðBSÞ
! Nonv iable Extremity
ðNEÞ
The probability provided by the meta-analysis,
P(NE = True|AR = Graft), is equivalent to marginalisation of ‘repair
failure’ and ‘blood supply’ from this pathway:
PðNE¼ TruejAR¼GraftÞ¼
X
BS;RF
PðNE¼ TruejBSÞPðBSjRFÞPðRFjAR¼GraftÞ
In our model, a repair failure always leads to inadequate blood
supply, and inadequate blood supply always leads to a nonviable
extremity so that:
PðBS ¼ LowjRF ¼ TrueÞ ¼ 1; PðNE ¼ TruejBS ¼ LowÞ ¼ 1;
PðBS ¼ LowjRF ¼ :TrueÞ ¼ 0; PðNE ¼ TruejBS ¼ :LowÞ ¼ 0
By using these values in the marginalisation equation above, we get
P(NE = True|AR = Graft) = P(RF = True|AR = Graft). Consequently, we
can use the probabilities from the meta-analysis for learning the
relation between ‘repair failure’ and its parents.
We used the OpenBUGS software [19] to calculate the posteri-
ors of the auxiliary learning model. We used the Gelman and Rubin
diagnostic technique [23], sample plots and autocorrelation plots
to assess the convergence. We discarded the ﬁrst 10,000 samples
in MCMC as the burn-in samples, and calculated the posterior dis-
tributions based on the next 70,000 samples.
Table 8 shows extracts of the NPTs of the ‘Repair Failure’ vari-
able and the amount of data available to learn its parameters.
The values written in bold and italic fonts are the parameters
Fig. 10. LEVT BN fragment for injuries below the knee.
Table 7
Amount of data available for learning parameters of repair failure variable.
ARa Graft Graft Graft Graft Graft Graft Primary Primary . . .
MAIa True True True False False False True True
ASa Femoral Popliteal Tibial Femoral Popliteal Tibial Femoral Popliteal
RFa 14 6 2 71 115 38 1 3 . . .
Number of observations:
a AR: Arterial Repair, MAI: Multiple Levels, AS: Anatomical Site, RF: Repair Failure.
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data, and the values written in normal fonts are the parameters
learned purely from the data. The results of these approaches differ
substantially as the data gets smaller. The effects of this difference
to the model performance are discussed in Section 5.1.4.4.2. Latent variables
The BN contained several latent variables as described in Sec-
tion 4.3 (see Table 6 for a list of these variables). Ranked nodes
were used to model the NPT of these variables [24]. A ranked node
is an approximation of the truncated normal distribution to the
multinomial distribution with ordinal scale. We used the frame-
work proposed by Fenton et al. [24] to elicit the parameters of
ranked nodes. For each of the latent variables we ﬁrst asked the
domain experts to describe the relation between the variable and
its parents. Afterwards, we selected a suitable ranked node func-
tion and elicited initial weights that imitate the described relation.
We presented the behaviour of the ranked node under various
combinations of observations to the domain experts, and reﬁned
the weights based on their comments.4.4.3. Variables with adequate amount of data
After the parameters with insufﬁcient or no data were deﬁned,
the remainder of the parameters were learned purely from the
data. The expectation–maximisation (EM) algorithm [25] was used
to learn those parameters as the dataset contained missing values.
Small correction factors were used at the maximisation step of the
EM algorithm to avoid zero probabilities. The parameters that were
already deﬁned in the previous steps were kept ﬁxed while EMwas
applied. For example, EM was applied to the parameters of the
‘Arterial Repair’ variable with more than 20 instances of data.
The other parameters of this variable had been already learnt byusing meta-analysis results at this stage, so they were kept ﬁxed
while the EM was applied.5. Results
The performance of the LEVT BN was evaluated using a 10-fold
cross-validation [26]. We used multiple performance measures to
assess the discrimination, calibration and accuracy of the model.
Receiver operating characteristic (ROC) curves, and sensitivity
and speciﬁcity values was used to assess the discrimination, the
Hosmer–Lemeshow (HL) [27] test was used to assess the calibra-
tion. The HL test divides the data into multiple subgroups, and cal-
culates a chi-square statistic comparing the observed outcomes to
the outcomes expected by the model in each subgroup. Low p-val-
ues indicate a lack of calibration. In large datasets, small differ-
ences between the expected and observed outcomes can lead to
low p-values in a HL test but the visual representation of this test
provides a concise summary of the model calibration. The Brier
score (BS) and Brier skill score (BSS) was used to assess the accu-
racy [28,29]. BS is the mean squared difference between the pre-
dicted probability and observed outcome. A BS of 0 indicates a
perfect model and 1 is the worst score achievable. BSS measures
the improvement of the model’s prediction relative to the average
probability of the event in the data or another reference probabil-
ity. A BSS of 1 indicates a perfect model, and a negative value indi-
cates a worse prediction than the average probability. The area
under the ROC curve (AUROC) of the LEVT BN was 0.91. When
operated at 80% and 90% sensitivity, the speciﬁcity was 81% and
70% respectively. BS and BSS of the LEVT BN were 0.06 and 0.33
respectively. The BN was well calibrated with a HL statistic of
12.7 (p-value: 0.13). Fig. 11 shows a graphical representation of
the HL tests. The predictions of the model are divided into deciles
in this ﬁgure; the expected number of outcomes according to the
Table 8
Parameters learnt purely from data and from a combination of data and meta-analysis.
ARa Graft Graft Graft Primary Primary
MAIa True True True . . . True True . . .
ASa Femoral Popliteal Tibial Femoral Popliteal
RFa . . ..
True 0.17 0.17 0.39 0.41 0.99 0.49 0.01 0.14 0.01 0.29 . . .
False 0.83 0.83 0.61 0.59 0.01 0.51 0.99 0.86 0.99 0.71
Number of observations 14 6 2 1 3
a AR: Arterial Repair, MAI: Multiple Levels, AS: Anatomical Site, RF: Repair Failure.
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each decile.5.1. Not compensating for the lack of data
The main reason of using our method for parameter learning
was that the available data were insufﬁcient to learn parts of the
BN structure. Since the BN model in Fig. 8 has a complicated struc-
ture compared to the available data, a purely data driven parame-
ter learning approach would probably overﬁt the model. To show
the consequences of not doing anything to compensate for the lack
of data, we learned the parameters of the same BN structure from
data without using any information from the meta-analysis. The
parameters of the variables that had no data (i.e. ranked nodes,
see Section 4.4.3) were deﬁned using the same parameters values
elicited from experts. The data-driven parameter learning algo-
rithm had poor discrimination, calibration and accuracy. The
AUROC was 0.68, the speciﬁcity was 29% and 45% at the 90% and
80% sensitivity levels, and the HL test indicated poor calibration
(p-value: 0.01). The BS and BSS were 0.10 and 0.02. Our method
outperformed the data-driven parameter learning algorithm in all
measures. In summary, the purely data driven parameter learning
overﬁtted the training data as the data was inadequate to learn
some parts of the BN parameters (Table 7). This underlines the
need to exploit other sources of information such as published evi-
dence. Our method overcomes the overﬁtting problem by using
information from the meta-analysis when the data is insufﬁcient.5.2. Mangled extremity severity score
The mangled extremity severity score (MESS) [30] is a well-
known scoring system [31] that was developed to provide decision
support in the management of patients with severe lower extrem-
ity injuries. MESS calculates a score based on the injury mecha-
nism, the degree of shock, the ischaemic status and the patient’s
age. If the score is above a certain threshold value MESS recom-
mends an early amputation. Our method outperformed MESS in
predicting the ‘Nonviable Extremity’ variable (Fig. 12). MESS had
an AUROC of 0.75. When operated at 90% and 80% sensitivity, itsFig. 11. Calibration of the LEVT BN.speciﬁcity was 40% and 60% respectively. The HL test indicated
poor calibration (p-value = 0.01). BS and BSS of MESS could not
be calculated as its outputs are not probabilities.
5.3. Purely data driven structure learning
We compared the performance of our method to three different
data-driven structure learning algorithms. These algorithms learn
both the structure and parameters from data so they do not use
expert knowledge at all in model development. These algorithms
avoid overﬁtting by penalising large BN structures. The following
structure algorithms were used:
1. A score based learning algorithm:hill climbing (HC) algorithm
with the BIC score [32–34].
2. A constraint based algorithm:grow shrink (GS) algorithm [33].
3. A combination of score and constraint based approaches:max–min
hill climbing (MMHC) algorithm [35].
4. A score based EM algorithm:structural EM (SEM) algorithm with
the BIC score [36].
The ﬁrst three algorithms require complete datasets so we
imputed the missing values in the dataset using the Amelia pack-
age [37] in the R statistical software for these algorithms (see
[37] for a description of the imputation technique used in Amelia).
The HC, GS and MMHC algorithms are readily implemented in the
BNLearn package of R [38]. The SEM algorithm is able to handle
missing values when learning structure therefore it is not
necessary to impute the missing values beforehand. We used the
SEM algorithm implemented in the structure learning package of
the Bayes net toolbox of Matlab [39].Fig. 12. ROC curves for the LEVT BN and MESS.
Table 9
Results of our method and the structure learning algorithms.
LEVT BN HC MMHC GS SEM
AUROC 0.91 0.83 0.83 0.84 0.84
Speciﬁcity (at 90% sensitivity) 70% 37% 41% 54% 43%
Speciﬁcity (at 80% sensitivity) 81% 71% 80% 69% 81%
Hosmer–Lemeshow test 12.7 (p = 0.13) 11.5 (p = 0.17) 15.3 (p = 0.05) 8.5 (p = 0.39) 13.5 (p = 0.10)
Brier score 0.06 0.07 0.07 0.07 0.07
Brier skill score 0.33 0.22 0.21 0.23 0.26
Fig. 13. BN structures learned by (A) HC, (B) MMHC, (C) GS⁄ and (D) SEM algorithms ⁄GS algorithm learns the structure with undirected arcs.
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formance at the operating points with higher sensitivity levels
(see Table 9). The LEVT BN had better BS and BSS than the structure
learning algorithms. The LEVT BN and BNs developed by HC and GS
approaches were well calibrated. Since the amount of data was
insufﬁcient to learn the relation between some variables, the struc-
ture learning algorithms avoided overﬁtting by learning simple BN
structures. The BN structures learned by HC, MMHC, GS and SEM
algorithms are shown in Fig. 13.6. Conclusion
This paper presented a novel methodology to build BN decision
support models from the results of a meta-analysis, expert knowl-
edge and data. The main contribution of this methodology was a
novel parameter learning technique that combines univariate sta-
tistics with data to learn multivariate BN parameters. Our method
was successfully applied to a trauma case-study of severely injured
lower extremities. We developed a BN model that accurately pre-
dicts the viability of a lower extremity with vascular trauma. The
case study demonstrated the beneﬁts of integrating different
sources of evidence into BN development. In a 10-fold cross-valida-
tion, the BN built by our approach outperformed the MESS scoring
system and four different data-driven structure learning
techniques. The AUROC of the LEVT BN was 0.91; whereas it was
0.84 for the best performing structure learning technique, 0.75
for MESS, and 0.68 when meta-analysis values were not used for
deﬁning the LEVT BN parameters.
The techniques presented in this paper can be applied to a
wider scope of problems than trauma care. Using our method,
models that reﬂect complexity of clinical decisions can be built
even when there is insufﬁcient patient data. Our method enables
the use of information from other sources such as published evi-
dence and meta-analysis of systematic reviews. It offers a Bayesian
way of combining multivariate patient data with published statis-
tics conditioned on a smaller number of variables.As further research, our auxiliary parameter learning model
could be expanded to a uniﬁed parameter learning framework that
combines data, published evidence and domain knowledge. Quali-
tative expert constraints [7,40,41] could be integrated into our
parameter learning method to incorporate expert knowledge
alongside data and meta-analysis. Moreover, the variance esti-
mated from the auxiliary parameter learning model (Section 3.2)
could be used to show how well the parameters are understood.
In our case study, we applied our parameter learning technique
to the parameters that had less than 20 instances of relevant data.
The effects using different data thresholds could be explored.
Finally, Bayesian parameter learning methods estimate the entire
probability distribution of a parameter. The expected value of this
distribution is used for the relevant NPT but the variance is often
ignored. Ways of integrating the variance to inference and
parameter estimation techniques could be investigated.
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